v3.26.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Aug. 31, 2026
Aug. 31, 2025
Cash Flows from Operating Activities:    
Net income (loss) $ 4,535,965 $ (167,328)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Interest earned on cash and investments held in Trust Account (5,820,815)
Changes in operating assets and liabilities:    
Prepaid expenses (129,668)
Long-term prepaid insurance (24,613)
Accrued expenses (34,989) 52,317
Accrued expenses – related party 101,804
Due to Sponsor 24,576
Deferred legal fees 413,467
Net cash used in operating activities (934,273) (115,011)
Cash Flows from Investing Activities:    
Investment of cash in Trust Account (230,000,000)
Notes receivable (255,000)
Cash withdrawn from Trust Account for working capital purposes 175,000
Net cash used in investing activities (230,080,000)
Cash Flows from Financing Activities:    
Proceeds from issuance of ordinary shares to Sponsor 25,000
Proceeds from sale of Units, net of underwriting discounts paid 226,000,000
Proceeds from sale of Private Placement Units 5,700,000
Proceeds from promissory note – related party 285,000
Repayment of promissory note – related party (300,000)
Repayment of advances from related party (17,845)
Due to Sponsor 252,101
Payment of offering costs (366,792) (129,992)
Net cash provided by financing activities 231,015,363 432,109
Net Change in Cash 1,090 317,098
Cash – Beginning of period 432
Cash – End of period 1,522 317,098
Non-cash investing and financing activities:    
Offering costs included in accrued offering costs 75,000 57,916
Offering cost paid through advances from Sponsor 5,500
Offering cost paid by Sponsor 1,400
Prepaid expenses applied to offering costs 25,000
Accretion of ordinary shares, subject to possible redemption to redemption value 24,393,931
Deferred underwriting fee payable $ 10,950,000